Clinical Trials
3 trialsNCT06687369 2026-03-11
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
mAbxience Research S.L.
Phase 3 Recruiting
NCT06939595 2025-04-23
A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
Celltrion
Phase 3 Recruiting
NCT05841472 2023-08-30
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
CrystalGenomics, Inc.
Phase 2 Recruiting